Terms: = Thyroid cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
17 results:
1.
Li F; Wu Y; Shi Y; Liu X; Xie Y; Liu S
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):462-473. PubMed ID: 38379418
[TBL] [Abstract] [Full Text] [Related]
2. Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission.
Guo YW; Zhu L; Duan YT; Hu YQ; Li LB; Fan WJ; Song FH; Cai YF; Liu YY; Zheng GW; Ge MH
Cell Death Dis; 2024 Feb; 15(2):125. PubMed ID: 38336839
[TBL] [Abstract] [Full Text] [Related]
3. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
Lee M; Morris LG
Oncotarget; 2024 Jan; 15():36-48. PubMed ID: 38275291
[TBL] [Abstract] [Full Text] [Related]
4. RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the jak1-STAT3-CD24/MMPs axis.
Zhang FX; Xu P; Zhang LJ; Fan R; Zhang HX; Liu DH; Liu K; Shen DY
Int Immunopharmacol; 2023 Dec; 125(Pt A):111129. PubMed ID: 37897947
[TBL] [Abstract] [Full Text] [Related]
5. RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast cancer and Beyond.
Wu J; Subbiah V
Cancer Res; 2023 Oct; 83(19):3159-3161. PubMed ID: 37779428
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
7. miR-518a-3p Suppresses Triple-Negative Breast cancer Invasion and Migration Through Regulation of TMEM2.
Gan L; Yang H; Xiong Z; Yang Z; Wang T; Lyu G
Technol Cancer Res Treat; 2020; 19():1533033820977523. PubMed ID: 33251982
[TBL] [Abstract] [Full Text] [Related]
8. Circular RNA DOCK1 downregulates microRNA-124 to induce the growth of human thyroid cancer cell lines.
Cui W; Xue J
Biofactors; 2020 Jul; 46(4):591-599. PubMed ID: 32584497
[TBL] [Abstract] [Full Text] [Related]
9. thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic thyroid cancer.
Bolf EL; Gillis NE; Davidson CD; Rodriguez PD; Cozzens L; Tomczak JA; Frietze S; Carr FE
Mol Cancer Res; 2020 Oct; 18(10):1443-1452. PubMed ID: 32554601
[TBL] [Abstract] [Full Text] [Related]
10. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles.
Keskitalo S; Haapaniemi E; Einarsdottir E; Rajamäki K; Heikkilä H; Ilander M; Pöyhönen M; Morgunova E; Hokynar K; Lagström S; Kivirikko S; Mustjoki S; Eklund K; Saarela J; Kere J; Seppänen MRJ; Ranki A; Hannula-Jouppi K; Varjosalo M
Front Immunol; 2019; 10():2770. PubMed ID: 31866997
[TBL] [Abstract] [Full Text] [Related]
11. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively.
Sola-Penna M; Paixão LP; Branco JR; Ochioni AC; Albanese JM; Mundim DM; Baptista-de-Souza D; Figueiredo CP; Coelho WS; Marcondes MC; Zancan P
Br J Cancer; 2020 Jan; 122(2):194-208. PubMed ID: 31819176
[TBL] [Abstract] [Full Text] [Related]
12. The Profile of Genetic Mutations in Papillary thyroid cancer Detected by Whole Exome Sequencing.
Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the jak1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract] [Full Text] [Related]
14. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
[TBL] [Abstract] [Full Text] [Related]
15. AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.
Couto JP; Almeida A; Daly L; Sobrinho-Simões M; Bromberg JF; Soares P
PLoS One; 2012; 7(10):e46869. PubMed ID: 23056499
[TBL] [Abstract] [Full Text] [Related]
16. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM
Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368
[TBL] [Abstract] [Full Text] [Related]
17. A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International).
Bosetti C; Negri E; Kolonel L; Ron E; Franceschi S; Preston-Martin S; McTiernan A; Dal Maso L; Mark SD; Mabuchi K; Land C; Jin F; Wingren G; Galanti MR; Hallquist A; Glattre E; Lund E; Levi F; Linos D; La Vecchia C
Cancer Causes Control; 2002 Oct; 13(8):765-75. PubMed ID: 12420956
[TBL] [Abstract] [Full Text] [Related]
